Cortechs.ai | 3.0 release brings change visualization to NeuroQuant<sup>®</sup>

3.0 release brings change visualization to NeuroQuant®

With the new release of NeuroQuant® 3.0, users will now have access to the change visualization output, previously available only through LesionQuant. Now compare two 3D T1 scans to detect and highlight the volumetric change within an easy to interpret heat map overlay. Users will see voxel-specific changes between the two scans highlighted in a color-coded heat map returned to the PACS system as a DICOM volume. The detailed 3D overlay provides high-resolution images to inform physicians of very subtle changes such as ventricle expansion, tissue atrophy and swelling that would otherwise be undetected by the human eye.

 

Sagital NQChange    NQChange Visualization AxialNQChange Visualization

 

The change analysis also highlights areas of significant volume changes that may be a result of medication, injury, or disease progression. This output fully integrates into the existing workflow and provides a DICOM overlay of co-registered and aligned images between time points.

To generate a change visualization output for NeuroQuant® or LesionQuant, the raw data from the baseline scan must be available in the NeuroQuant® database. If the baseline data is available, NeuroQuant® and LesionQuant will automatically generate change visualization outputs if the scan protocols are comparable. If baseline data is not available, the user will upload the baseline scan 3D T1 (and FLAIR for LesionQuant) for analysis, then upload the current time point data.

NeuroQuant® 2.3 will continue to be available to all customers however all new features will only be available with NeuroQuant® 3.0. Learn more about the new and improved features NeuroQuant® 3.0 can bring to you and your patients.

Ready to upgrade to 3.0? Click here to request migration to NeuroQuant® 3.0.

 

More Resources

09/29/2025

The Role of NeuroQuant in Supporting Alzheimer’s Disease Care

NeuroQuant equips clinicians and researchers with data that can support earlier recognition of disease, track progression, and evaluate treatment efficacy.

09/16/2025

OnQ Prostate for Focal Therapy

Read how OnQ Prostate supports focal therapy by personalizing prostate cancer care for patients while minimizing the risks associated with it.

09/03/2025

Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T

Learn how Cat. III CPT codes 0648T and 0649T apply to OnQ™ Prostate, offering guidance for accurate reporting, reimbursement, and building evidence for coverage

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.
Scroll to Top